Cepheid Genexpert Consumables & Reagents Cincinnati VA Medical Center

This is a Sources Sought Notice only, not a solicitation announcement and should not be considered as such. There is no solicitation available at this time. The Government will not pay for any information received in response to this notice, nor will the Government compensate any respondent for any cost incurred in developing the information provided. This notice does not constitute a commitment by the Government.

Any information provided in response to this market survey will be used for informational purposes only and will not be released. Vendor participation is not a promise of future business with the Government. The purpose of this notice is to conduct market research to determine an acquisition strategy for the establishment of Cepheid Reagents for a base year contract plus four 1-year ordering options.

Pathology & Laboratory Medicine Service needs to procure reagents and consumables for the Cepheid GeneXpert System currently used at the Cincinnati VA Medical Center (CVAMC), Pathology & Laboratory Medicine Service (P&LMS). This analyzer performs Influenza A (Flu A), Influenza B (Flu B), Respiratory Syncytial Virus (RSV), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV2), and Group A Streptococcus (Strep A) testing. Only cartridges manufactured by Cepheid will work with this analyzer.

It is proprietary in nature, and the configuration is such that only a specific cartridge will fit into the analyzer. The Department of Veterans Affairs, Network Contracting Office 10, is conducting market research to determine if there are any Large Businesses and if there are a sufficient number of Small Businesses capable of performing the requirements to warrant a set-aside.

The proposed solicitation is to furnish all materials, labor, and transportation required to provide reagents and consumables to the Department of Veterans Affairs, CVAMC. The Contractor shall also comply with any other federal, state, and local laws applicable to the industry. Potential sources must demonstrate experience and knowledge of required services and capability to provide such services.

Potential sources should submit: Business name and address; Point of contact and Email; Business size, and any applicable business socio-economic category; Capability statement; Provide information for recent and relevant projects similar in nature; SAM Unique Entity Identifier (UEI) number; Contract number if applicable; Brochure of equipment; and County of origin for manufacturing. The North American Industry Classification System (NAICS) code is 325413 In-Vitro Diagnostic Substance Manufacturing.

The small business size standard is 1,250 Employees. The Product Service Code (PSC) is 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets Responses to this notice shall be e-mailed to Barbara Robertson at Barbara.Robertson@va.gov. Enter RFQ 36C25026Q0404 / Cepheid Reagents CVAMC in the email subject line. Telephone responses will not be accepted.

Responses must be received in writing no later than (NLT) 12:00 PM EDT, Tuesday, March 24, 2026. This notice is to assist the VA in determining sources only. A solicitation is not currently available.